- Consumer Products
- Latest 1.12
- Currency C$
- Change 0.21
- Percent Change 23.077 %
- Volume 608,888
- Fri Oct 31, 2014 03:59 PM EDT TSX data delayed 15 minutes.
12 months ended Jun 30, 2014.
Trailing 12 month results shown above.
All data is in Canadian dollars.
|Earnings||Aug 7||$-0.07||Nov 6||$-0.07|
12 months ended Oct 31, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
ONCOLYTICS BIOTECH INC. is a biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN, its proprietary formulation of the human reovirus.